Syner Medico Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-05-2024
- Paid Up Capital ₹ 0.10 M
as on 30-05-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -69.88%
(FY 2022)
- Profit -65.62%
(FY 2022)
- Ebitda -33.32%
(FY 2022)
- Net Worth 31.23%
(FY 2022)
- Total Assets -8.16%
(FY 2022)
About Syner Medico
The Corporate was formerly known as Swiss Medicos (India) Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naishadh Shah and Vikrambhai Shah serve as directors at the Company.
- CIN/LLPIN
U24230GJ2009PTC056209
- Company No.
056209
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Syner Medico?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naishadh Shah  | Director | 24-Feb-2009 | Current |
| Vikrambhai Shah | Director | 24-Feb-2009 | Current |
Financial Performance and Corporate Structure Insights of Syner Medico.
Syner Medico Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 69.88% decrease. The company also saw a substantial fall in profitability, with a 65.62% decrease in profit. The company's net worth Soared by an impressive increase of 31.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syner Medico?
In 2017, Syner Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swiss Bio-Pharma Private LimitedActive 14 years 3 monthsNaishadh Shah and Vikrambhai Shah are mutual person
- Swiss Nutraceuticals Private LimitedActive 14 years 3 months
Naishadh Shah and Vikrambhai Shah are mutual person
- Swiss Exports Private LimitedActive 25 years 11 months
Naishadh Shah and Vikrambhai Shah are mutual person
Healthbest Private LimitedActive 7 years 2 monthsNaishadh Shah and Vikrambhai Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syner Medico?
Unlock and access historical data on people associated with Syner Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syner Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syner Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
